Eton Pharmaceuticals Inc’s filing revealed that its 10% Owner Opaleye Management Inc. acquired Company’s shares for reported $79814.0 on Oct 23 ’24. In the deal valued at $7.98 per share,10,000 shares were bought. As a result of this transaction, Opaleye Management Inc. now holds 2,770,000 shares worth roughly $32.77 million.
Then, Opaleye Management Inc. bought 33,970 shares, generating $238,782 in total proceeds. Upon buying the shares at $7.03, the 10% Owner now owns 2,760,000 shares.
Before that, Opaleye Management Inc. bought 16,852 shares. Eton Pharmaceuticals Inc shares valued at $114,105 were divested by the 10% Owner at a price of $6.77 per share. As a result of the transaction, Opaleye Management Inc. now holds 2,720,000 shares, worth roughly $32.18 million.
H.C. Wainwright reiterated its Eton Pharmaceuticals Inc [ETON] rating to a Buy in a research note published on January 23, 2025; the price target was $33. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. H.C. Wainwright also remained covering ETON and reiterated its “Buy” recommendation on January 06, 2025.
Price Performance Review of ETON
On Friday, Eton Pharmaceuticals Inc [NASDAQ:ETON] saw its stock fall -5.36% to $11.83. Over the last five days, the stock has lost -9.14%. Eton Pharmaceuticals Inc shares have fallen nearly -11.19% since the year began. Nevertheless, the stocks have risen 228.61% over the past one year. While a 52-week high of $18.41 was reached on 02/05/25, a 52-week low of $3.03 was recorded on 04/04/25. SMA at 50 days reached $15.27, while 200 days put it at $9.51.
Levels Of Support And Resistance For ETON Stock
The 24-hour chart illustrates a support level at 11.31, which if violated will result in even more drops to 10.79. On the upside, there is a resistance level at 12.29. A further resistance level may holdings at 12.75. The Relative Strength Index (RSI) on the 14-day chart is 32.90, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.57%. Stochastics %K at 17.56% indicates the stock is a buying.
How much short interest is there in Eton Pharmaceuticals Inc?
A steep rise in short interest was recorded in Eton Pharmaceuticals Inc stocks on 2025-03-14, dropping by -0.12 million shares to a total of 0.24 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 0.35 million shares. There was a decline of -49.81%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 06, 2024 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
